Drugs / Calcipotriene/betamethasone
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00608777 | Jan 2008 → Feb 2009 | psoriasis | Derm Research, PLLC | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Calcipotriene/betamethasone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00608777 ↗ |
| Route | Topical | “Topical calcipotriene/betamethasone (Taclonex) will be applied to the areas (except face, axillae or groin) once a day for two weeks.” NCT00608777 ↗ |